Christopher Yea Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity
Christopher Yea is CHIEF DEVELOPMENT OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 80,074 shares of KALV, which is worth approximately $934,463. The most recent transaction as insider was on May 20, 2024, when has been sold 11,610 shares (Common Stock) at a price of $11.76 per share, resulting in proceeds of $136,533. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
80.1K
9.85%
3M change
114.62%
12M change
Total Value Held
$934,463
Christopher Yea Transaction History
CY
Christopher Yea
CHIEF DEVELOPMENT OFFICER
Cambridge, MA